ArticleJournal of veterinary internal medicine2021
Choledochal stenting for treatment of extrahepatic biliary obstruction in cats.
Article in Journal of veterinary internal medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed, 11 citations in OpenAlex.
- Application of Self-Expandable Metal Stent in Dogs and Cats for the Management of Extrahepatic Biliary Obstruction: 13 Cases (2021-2024).Veterinary medicine and science · 2025Article
- Prognostic Factors in 26 Cats Undergoing Surgery for Extra-Hepatic Biliary Obstruction.Veterinary sciences · 2024Article
- Combined cholecystotomy, retrograde hydropulsion, and choledochal stenting to treat extrahepatic biliary tract obstruction in 3 cats.The Canadian veterinary journal = La revue veterinaire canadienne · 2024Article
- Surgical Management Of Feline Biliary Tract Disease: Decision-making and techniques.Journal of feline medicine and surgery · 2023Review
- Surgical Anatomy of the Gastrointestinal Tract in Cats.Animals : an open access journal from MDPI · 2023Review
- Choledochal stenting for treatment of extrahepatic biliary obstruction in cats.Journal of veterinary internal medicine · 2021Article
- Prevalence and clinical relevance of cholelithiasis in cats: A multicenter retrospective study of 98 cases.Journal of veterinary internal medicineArticle
- Choledochoduodenostomy in a cat with extrahepatic biliary obstruction: simple side-to-side anastomosis technique.JFMS open reportsArticle
- Use of a Modified Transhepatic Rendezvous Technique for Stenting of Malignant Biliary Obstruction in 2 Cats.Journal of veterinary internal medicineArticle
- Common bile duct perforation due to choledocholithiasis in a cat with gallbladder agenesis.JFMS open reportsArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors at 6 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundLimited information currently exists regarding the clinical progression and outcomes of cats that undergo choledochal stenting as a treatment for extrahepatic biliary obstruction (EHBO). HYPOTHESIS/
objectivesDescribe clinical characteristics, indications for choledochal stent placement, procedure, and outcomes in a cohort of cats undergoing choledochal stenting and evaluate risk factors associated with survival as well as recurrence of EHBO in affected cats. ANIMALS: Twenty-three client-owned cats undergoing choledochal stent placement.
methodsRetrospective study. Medical records from 6 academic institutions were reviewed, and data were extracted and analyzed statistically.
resultsMedian age of cats was 10.1 years (range, 2-16), and all cats had at least 2 clinical signs. Most common clinical signs were vomiting in 20/22 (90.9%), inappetence in 19/22 (86.4%), and lethargy in 19/23 (82.6%). Procedural complications were uncommon and rarely related to the stenting procedure. Clinical signs improved postoperatively in 15/20 (75.0%) cats and serum total bilirubin concentration decreased postoperatively in 13/19 (68.4%) cats. Eighteen (78.3%) cats survived to discharge. Recurrence of EHBO was documented in 7/18 (38.9%) cats that survived to discharge. Cholelithiasis was associated with recurrence of EHBO. Median survival time for cats that survived to discharge was 931 days (range, 19-3034). Absence of peritoneal effusion was associated with survival to discharge. CONCLUSIONS AND CLINICAL IMPORTANCE: Choledochal stenting was an effective treatment modality in cats with EHBO with few procedural complications and potential for prolonged survival, but substantial risk for recurrence of EHBO was identified.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.